ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

March 22, 2013

Obey Questions NCI honesty, Transfers IARC Monograph Support To NIH

October 15, 1982

Contract Awards Sole Source Negotiations

January 13, 1978

House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe

March 22, 2013

In Brief: Einhorn Named Karnofsky Lecturer; Consensus Conferences On Colon, Breast Cancer Planned

February 2, 1990

Six Centers Win Grants

July 11, 2003